BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3874418)

  • 1. Serum immunosuppressive acidic protein in adult T-cell leukaemia (ATL).
    Tagawa S; Sawada M; Tokumine Y; Ueda E; Machii T; Hayashi S; Kurata Y; Kitani T
    Scand J Haematol; 1985 May; 34(5):360-9. PubMed ID: 3874418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study on the serum carcinoembryonic antigen, immunosuppressive acidic protein and C-reactive protein levels in patients with adult T cell leukemia].
    Kumagai E; Ogata M; Maeda Y; Kumagai T; Okajima K; Yamaguchi K; Tanoue S
    Rinsho Byori; 1989 Jul; 37(7):769-73. PubMed ID: 2607647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical study on the serum levels of immunosuppressive acidic protein in patients with adult T-cell leukemia.
    Kumagai E; Kumagai T; Tanoue S; Asou N; Yamaguchi K; Okabe H; Yoshida M; Takatsuki K
    Acta Haematol; 1988; 79(3):157-60. PubMed ID: 2895561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical adult T-cell leukemia-lymphoma: diverse clinical manifestations of adult T-cell leukemia-lymphoma.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Setoya T; Takenaka T; Ishihara K; Watanabe S; Hoshino H; Miwa M; Kinoshita M; Okabe S; Fukushima N; Inada N
    Jpn J Clin Oncol; 1983; 13 Suppl 2():165-87. PubMed ID: 6603526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and biological significance of serum tumor markers in adult T-cell leukemia.
    Sadamori N
    Leuk Lymphoma; 1996 Aug; 22(5-6):415-9. PubMed ID: 8882954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult T-cell leukemia (ATL) virus-specific antibodies in ATL patients and healthy virus carriers.
    Yamamoto N; Schneider J; Koyanagi Y; Hinuma Y; Hunsmann G
    Int J Cancer; 1983 Sep; 32(3):281-7. PubMed ID: 6604032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary excretion of parathyroid hormone-related protein in patients with adult T-cell leukemia and other hematologic disorders].
    Mori N; Ohsumi K; Murakami S; Wake A; Nakata K; Misago M; Oda S; Eto S
    Rinsho Ketsueki; 1992 Sep; 33(9):1158-65. PubMed ID: 1433936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-ATLA (antibody to adult T-cell leukemia-lymphoma virus-associated antigen)-negative adult T-cell leukemia-lymphoma.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Setoya T; Watanabe S; Hoshino H; Miwa M; Nagoshi H; Ichiki N; Fukushima N; Sugiura K; Funaki N
    Jpn J Clin Oncol; 1983; 13 Suppl 2():245-56. PubMed ID: 6603533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proposal for smoldering adult T-cell leukemia: a clinicopathologic study of five cases.
    Yamaguchi K; Nishimura H; Kohrogi H; Jono M; Miyamoto Y; Takatsuki K
    Blood; 1983 Oct; 62(4):758-66. PubMed ID: 6224522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine deaminase in plasma of patients with adult T-cell leukemia (ATL): correlation between enzyme activity and the ATL subtypes.
    Oda T; Kagimoto T; Aso N; Yamaguchi K; Tomino S; Takatsuki K
    Hematol Oncol; 1985; 3(3):173-7. PubMed ID: 2995223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses and serum levels of cytokines in adult T-cell leukemia patients and human T-cell leukemia virus type-I carriers.
    Nakasone T; Araki K; Masuda M; Oshiro K; Arakaki H; Shimoji T; Shinzato O; Mimura G
    Eur J Haematol; 1992 Feb; 48(2):99-104. PubMed ID: 1547882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proposal for smoldering adult T-cell leukemia--diversity in clinical pictures of adult T-cell leukemia--.
    Yamaguchi K; Nishimura H; Kawano F; Kohrogi H; Jono M; Miyamoto Y; Takatsuki K
    Jpn J Clin Oncol; 1983; 13 Suppl 2():189-99. PubMed ID: 6603527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic and epidemiologic studies on adult T-cell leukemia (ATL): special reference to a comparison between patients with and without antibody to ATL-associated antigen.
    Takenaka T; Nakamine H; Oshiro I; Maeda J; Kobori M; Hayashi T; Komoda H; Hinuma Y; Hanaoka M
    Jpn J Clin Oncol; 1983; 13 Suppl 2():257-67. PubMed ID: 6603534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum soluble interleukin-2 receptor levels in patients with adult T-cell leukemia and human T-cell leukemia/lymphoma virus type-I seropositive healthy carriers.
    Motoi T; Uchiyama T; Uchino H; Ueda R; Araki K
    Jpn J Cancer Res; 1988 May; 79(5):593-9. PubMed ID: 2900231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study.
    Hinuma Y; Komoda H; Chosa T; Kondo T; Kohakura M; Takenaka T; Kikuchi M; Ichimaru M; Yunoki K; Sato I; Matsuo R; Takiuchi Y; Uchino H; Hanaoka M
    Int J Cancer; 1982 Jun; 29(6):631-5. PubMed ID: 6980846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive acidic protein in patients with ovarian cancer.
    Sawada M; Okudaira Y; Matsui Y; Shimizu Y
    Cancer; 1983 Dec; 52(11):2081-5. PubMed ID: 6627216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-specific antibodies in patients with adult T-cell leukemia (ATL) and healthy ATL virus-carriers.
    Imai J; Hinuma Y
    Int J Cancer; 1983 Feb; 31(2):197-200. PubMed ID: 6298126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum immunosuppressive acidic protein levels in blackfoot disease patients and cancer patients.
    Lu FJ; Chang KJ; Chen BH; Liaw FR; Liau SR; Chen HY
    J Formos Med Assoc; 1990 Apr; 89(4):255-8. PubMed ID: 1976740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
    Sakita M; Yamane T; Kasuga M; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1755-64. PubMed ID: 7184372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive substance in the sera of head and neck cancer patients.
    Yamanaka N; Harabuchi Y; Himi T; Kataura A
    Cancer; 1988 Oct; 62(7):1293-8. PubMed ID: 3416271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.